Time |
Program |
Speaker |
08:30 – 10:00 |
Plenary Symposium 2
Advances in Dialysis Techniques |
Convention Hall B |
| |
Chairpersons: Dr. RL Mehta &
Prof. Philip Li |
|
08:30 – 08:45 |
PS2.1- The Best Dialysis Therapy? Results from
an International Survey among Nephrology Professionals
|
Dr. Ingrid Ledebo
|
08:45 – 09:10 |
PS2.2- Advances in Dialysis Membrane Material
& Configuration [
presentation] |
Prof. Claudio Ronco |
09:10 – 09:35 |
PS2.3- Online Hemodiafiltration [
presentation] |
Prof. Bernard Canaud |
09:35 – 10:00 |
PS2.4- Wearable Artificial Kidney & Artificial
Nephron System |
Dr. Victor Gura |
10:00 – 11:00 |
Poster Viewing |
Convention & Theatre Foyer |
11:00 – 12:30 |
Symposium 1 
Hemodialysis Dose and Flux |
Theatre 1 |
| |
Chairpersons: Dr. YF
Lin & Dr. KL Tong |
11:00 – 11:30 |
CS1.1- What is Most Important in HD: Treatment
Frequency, Treatment Time, Dose or Membrane Flux
?
[
presentation] |
Prof. Peter Kerr |
11:30 – 12:00 |
CS1.2- High Flux Dialysis : Lessons Learned
from MPO and HEMO Studies [
presentation] |
Prof. Francesco Locatelli |
12:00 – 12:30 |
CS1.3- Adequacy of Dialysis: Update on KT/V
and Volume Control |
Dr. Madhukar Misra |
| |
11:00 – 12:30 |
Symposium 2
Cardiovascular Disease |
Theatre 2 |
| |
Chairpersons: Prof.
Ho Yung Lee & Prof. KN Lai
|
11:00 – 11:30 |
CS2.1- Advances in Our Understanding of Vascular
Calcification [
presentation] |
Prof. Kosaku Nitta |
11:30 – 12:00 |
CS2.2- Brain Natriuretic Peptide – Marker
or Therapeutic Agent ? |
Prof. Carmine Zoccali |
12:00 –
12:30 |
CS2.3- Controversies in the Treatment of Hyperlipidaemia
in Dialysis Patients [
presentation] |
Dr. Bonnie CH Kwan |
12:30 – 14:00 |
Lunch Symposium ( Sponsored by FMC ) |
Convention Hall B |
| |
Chairperson: Prof. Alex
Yu |
|
LS1.1- Achieving Superior Outcomes in Dialysis
Patients |
Prof. Bernard Canaud & Dr. Feidhlim
Woods |
| |
12:30 – 14:00 |
Lunch Symposium (sponsored by Kyowa
Kirin ) Advances in Secondary
Hyperparathyroidism Treatment by Calcimimetic
Agent |
Convention Hall A |
| |
Chairpersons: Prof.
Carmine Zoccali & Prof. Philip
Li |
12:30 – 13:00 |
LS2.1- Phosphate Control in Hemodialysis “Cinacalcet
in Control of Secondary Hyperparathyroidism”
[
presentation]
|
Prof. Angel L de Francisco |
13:00 –
13:30 |
LS2.2- Impact of Cinacalcet on the Management
of CKD-MBD: Asian Perspectives |
Prof. Tadao Akizawa |
| |
|
14:00 – 15:30 |
Symposium 3 
Nursing Matters in Hemodialysis |
Theatre 1 |
| |
Chairpersons: Prof.
Josephine Chow & Ms. Frances
Chiu |
14:00 – 14:30 |
CS3.1- Roles of Renal Nurse in a Hemodialysis
Unit
[
presentation] |
Ms. Miki Hiramatsu |
14:30 – 15:00 |
CS3.2- Vascular Access Management [
presentation] |
Ms. Lesley Dinwiddie |
15:00 – 15:30 |
CS3.3- Nocturnal Home Hemodialysis
Training Programme in Hong Kong [
presentation] |
Ms. Irene Kong |
| |
14:00 – 15:30 |
Free Communications 1 |
Theatre 2 |
| |
Chairpersons: Dr. Kazo
Kaizu & Prof. Chang-Lin Mei |
14:00 – 14:10 |
FC1.1- [027] Prolonged Temporary Hemodialysis
Catheter Survival with Copolymer Coating in Patients
with End-stage Renal Disease - PROCOP Study [
presentation] |
Prof. Pascal Meier |
14:10 – 14:20 |
FC1.2- [165] Effect of Lowering Dialysate Calcium
Concentration on Arterial Stiffness in Hemodialysis
Patients [
presentation] |
Dr. Jwa-Kyung Kim |
14:20 – 14:30 |
FC1.3- [022] Pulmonary Hypertension in
Chronic Kidney Disease in a Multi-ethnic
Asian Population
[
presentation] |
Dr. KB Lim |
14:30 – 14:40 |
FC1.4- [058] The Effect of Treg/Th17 Functional
Imbalance on Development and Outcome of Adverse
Cardiovascular Events in Uremia Patients With
Maintenance Hemodialysis [
presentation] |
Dr. Jianbin Zhang |
14:40 – 14:50 |
FC1.5- [071] Outcome of The Hemodialysis Catheter
Related Bacteraemia Treated With Systemic Antibiotics
And Antibiotic Lock Therapy-A Single Centre Experience
[
presentation]
|
Dr. SK Chan |
14:50 – 15:00 |
FC1.6- [088] Strategic Reduction in Hemodialysis
Catheter Related Bloodstream Infections [
presentation] |
Ms. CMK Tang |
15:00 – 15:10 |
FC1.7- [103] Serum Adiponectin is Associated
with Ankle-Brachial Index Inpatients on Hemodialysis
[
presentation]
|
Dr. Yi-Jun Zhou |
15:10 – 15:20 |
FC1.8- [147] Type of Thrombus Formation in Hemodialysis
Blood Tubing Lines [
presentation] |
Dr. N Kimata |
15:20 – 15:30 |
FC1.9- [193] Validation of Glucose Dilution
Technique as a Test for Arteriovenous Fistula
Recirculation Evaluation in Hemodialysis
|
Prof. F Jarraya |
| |
|
14:00 – 15:30 |
Free Communications 2 |
Room S228 |
| |
Chairpersons: Prof.
Lina Choong & Dr. Sydney
Tang |
14:00 – 14:10 |
FC2.1- [031] Baseline Peritoneal Ultrafiltration
Capability Predicts Survival of Hemodialysis Patients
[
presentation]
|
Dr. CC Szeto |
14:10 – 14:20 |
FC2.2- [072] Brain Natriuretic Peptide Levels
Have Diagnostic and Prognostic Utility for Cardiac
Events in Patients with Chronic Kidney Disease
Admitted to the Intensive Care Unit [
presentation] |
Prof. Sung Gyun Kim |
14:20 – 14:30 |
FC2.3- [080] Substantial Improvement in Peritoneal
Dialysis Survival Compared with Hemodialysis in
the United States- A Longitudinal Trend Analysis:
1995-2004
[
presentation] |
Dr. AG Stack |
14:30 – 14:40 |
FC2.4- [089] An Investigation into the Quality
of Life of Chronic Hemodialysis Patients Managed
with Outcome Driven Protocols in South Africa
[
presentation]
|
Ms. CL Becker |
14:40 – 14:50 |
FC2.5- [106] Comparison of Two Years Outcome
in Maintenance Dialysis Lupus Nephritis Patients
[
presentation]
|
Dr. Mingli Zhu |
14:50 – 15:00 |
FC2.6- [107] Prognostic Value of Access Blood
Flow in Hemodialysis Patients [
presentation] |
Dr. XJ Che |
15:00 – 15:10 |
FC2.7- [118] The Effects of Proactive Iron Protocol
Implementation on Achieving Clinical Guideline
Targets for Anaemia in a Satellite Hemodialysis
Patient Cohort
[
presentation] |
Dr. K Yong |
15:10 – 15:20 |
FC2.8- [121] Post-parathyroidectomy Hypocalcemia
in Hemodialysis Patients with Renal Hyperparathyroidism:
Incidence and Risk Factors [
presentation] |
Dr. CHR Tan |
15:20 – 15:30 |
FC2.9- [189] Renal Replacement Therapy for Management
of Inborn Errors of Metabolism in Neonates
[
presentation] |
Dr. ALT Ma |
15:30 – 16:00 |
Coffee Break |
Convention & Theatre Foyer |
16:00 – 17:30 |
Symposium 4 
Vascular Access |
Theatre 1 |
| |
Chairpersons: Prof.
Christopher Blagg & Dr. CB
Leung |
16:00 – 16:30 |
CS4.1- Drug Therapy for Prevention of Vascular
Access Stenosis [
presentation] |
Dr. Akira Saito |
16:30 – 17:00 |
CS4.2- Intervention Radiology for Vascular Access
Problems |
Dr. Philip CH Kwok |
17:00 – 17:30 |
CS4.3- Medication Lock for Dialysis Catheter-
When, and What is the Evidence ? [
presentation] |
Dr. KM Chow |
| |
16:00 – 17:30 |
Symposium 5
Hemodialysis in Children |
Theatre 2 |
| |
Chairpersons: Dr. Un
I Kuok & Dr. WM Lai |
16:00 – 16:30 |
CS5.1- Practice of Continuous Renal Replacement
Therapy in Children |
Prof. Hui-Kim Yap |
16:30 – 17:00 |
CS5.2- Vascular Access in Children [
presentation] |
Dr. MK Yiu |
17:00 – 17:30 |
CS5.3- Nutrition and Dietary Management of Pediatric
Dialysis Patients |
Prof. Hui-Kim Yap |
17:50 – 19:00 |
Evening Symposium ( sponsored by Baxter
)
The role of APD in ESRD care in Asia
Pacific – an alternative to ICHD
|
Theatre 1 |
| |
Chairperson: Prof. Philip
Li |
|
Debate: Modality Selection - APD versus In-centre
HD |
Dr. Wai Kei Lo & Prof. Peter Kerr |
19:15 – 22:00 |
Gala Dinner |
Convention Hall |